Cite
HARVARD Citation
Nookala, A. et al. (2018). Direct‐acting antiviral regimens are safe and effective in the treatment of hepatitis C in simultaneous liver–kidney transplant recipients. Clinical transplantation. 32 (3), p. n/a. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Nookala, A. et al. (2018). Direct‐acting antiviral regimens are safe and effective in the treatment of hepatitis C in simultaneous liver–kidney transplant recipients. Clinical transplantation. 32 (3), p. n/a. [Online].